» Articles » PMID: 12782596

A Novel Single Nucleotide Polymorphism Within the 5' Tandem Repeat Polymorphism of the Thymidylate Synthase Gene Abolishes USF-1 Binding and Alters Transcriptional Activity

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Jun 5
PMID 12782596
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Thymidylate synthase (TS) gene expression is modulated by a polymorphism in the 5' regulatory region of the gene. The polymorphism consists mainly of either two repeats (2R) or three repeats (3R) of a 28-bp sequence, yielding greater TS gene expression and protein levels with a 3R genotype. Two USF family E-box consensus elements are found within the tandem repeats of the 3R genotype, and one is found within the 2R genotype. These elements bind USF proteins in vitro by electrophoretic mobility shift analysis and in vivo by chromatin immunoprecipitation assay. We show that the additional USF consensus element within the 3R construct confers greater transcriptional activity relative to the 2R construct. Mutagenesis of the USF sites shows that the transcriptional regulation of TS is dependent, in part, on USF proteins binding within the tandem repeats. In addition, we identified a novel G-->C single nucleotide polymorphism in the second repeat of 3R alleles within the USF consensus element that alters the ability of USF proteins to bind and thus alters the transcriptional activation of TS gene constructs bearing this genotype. Through RFLP analysis, we determined the respective frequencies of the C allele (3RC) among all 3R alleles in non-Hispanic whites, Hispanic whites, African Americans, and Singapore Chinese to be 56%, 47%, 28%, and 37%, respectively. Based on our findings, this novel single nucleotide polymorphism should be considered when the 5' tandem repeat polymorphism is being used as a predictor of clinical outcome to TS inhibitors.

Citing Articles

Material basis revelation of anti-hepatoma effect of Huachansu (Cinobufacini) through down-regulation of thymidylate synthase.

Wu Q, Chen Q, Yang J, Zhang J, Yang A Chin Herb Med. 2025; 17(1):127-138.

PMID: 39949800 PMC: 11814253. DOI: 10.1016/j.chmed.2024.04.002.


Prognostic and Predictive Determinants of Colorectal Cancer: A Comprehensive Review.

Cotan H, Emilescu R, Iaciu C, Orlov-Slavu C, Olaru M, Popa A Cancers (Basel). 2024; 16(23).

PMID: 39682117 PMC: 11640109. DOI: 10.3390/cancers16233928.


Impact of TYMS gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients - identification of novel single nucleotide polymorphism: Cross-sectional study.

Mutlak Q, Kasim A, Aljanabi A Medicine (Baltimore). 2024; 103(23):e38448.

PMID: 38847705 PMC: 11155610. DOI: 10.1097/MD.0000000000038448.


Evaluation of TS and ENOSF1 Variants as a Biomarker in Response to Neoadjuvant Chemotherapy based on 5FU in Gastric Cancer Patients.

Arjmandi K, Ameli F, Salahshourifar I, Esfandbod M, Irani S Asian Pac J Cancer Prev. 2022; 23(9):2983-2989.

PMID: 36172660 PMC: 9810307. DOI: 10.31557/APJCP.2022.23.9.2983.


Thymidylate synthase locus LOH in combination with genotype has prognostic and predictive significance in colorectal cancer.

Kotake M, Bando H, Kaneko M, Takemura H, Minamoto T, Kawakami K Mol Clin Oncol. 2021; 15(5):235.

PMID: 34650802 PMC: 8506693. DOI: 10.3892/mco.2021.2398.